The pathogenesis of poliomyelitis has been studied intensively during the past fifty years by many investigators, yet our understanding of the course of events in the human infection is far from perfect. There are still many controversial issues, in general the same issues with which the early investigators were also concerned: viz., is poliomyelitis an entirely neural disease, or is there a systemic, extraneural phase? In what tissues does virus first multiply? How does it invade the central nervous system-from the blood or exclusively by neural pathways? What are the immune barriers against infection and paralysis and where do they operate?
In the discussion today, I should like first to review the current status of some of these problems, and subsequently to describe observations on humans infected with attenuated strains of poliovirus as they relate to certain aspects of the pathogenesis and immune mechanisms.
Current concepts of the nature of poliomyelitis lean toward an interpretation of the infection as primarily an extraneural one in which significant CNS invasion occurs only rarely. This is not a new idea. It was in fact the point of view expressed by Peabody, Draper, and Dochez in 191240 and by other investigators at that time. But it was lost sight of in the enthusiasm for neurotropic aspects of the infection which were studied so extensively in the ensuing 25 years, largely by inoculating monkeys either intranasally or directly into nervous tissue and employing almost exclusively the MV strain, which had become highly neurotropic by many neural passages. The return to a more natural perspective in terms of the human infection came in the early 1940's, when through the work of Harmon,' Trask, Vignec, and Paul,' Sabin and Ward,' and others, it became apparent that infection of the alimentary tract is an important phase in the pathogenesis of poliomyelitis. Renewed interest in the pathogenesis of poliomyelitis was stimulated by the discovery beginning in 1951 that a phase of viremia occurs in infection.' ' Subsequently, the use of quantitative tissue culture methods of virus and antibody assay and the many new observations by Koprowski et al."'1 and Sabin"' e"" on humans infected with attenuated strains have considerably enlarged our understanding of the pathogenesis of poliomyelitis. There is now general agreement on the alimentary portal of entry, and it is known that the vulnerability of different parts of the alimentary tract to virus implantation and multiplication differs in different species. In man, the lower intestinal tract (ileum) is more susceptible than the throat, while the reverse is true in monkeys? and chimpanzees.'1 Sabin4e has demonstrated that larger doses of virus are required to infect the throat than the intestinal tract of susceptible persons; we have found the same to be true in reinfection of naturally immune individuals.= The fact that the throat can be by-passed-as it was in children fed attenuated virus in capsules in a human trial to be described later-adds further evidence that multiplication of poliovirus in the throat is not an essential part of human infection.
SITES OF PRIMARY VIRAL MULTIPLICATION
Does virus multiply first in mucosal cells or in lymphoid tissues of the alimentary tract? Or does it avoid both of these and make its way to regional ganglia before multiplying?
The speed with which virus appears in the throat and feces-44' in humans after ingestion of attenuated strains-as short as 24 hours-would seem to narrow the field to a readily available cell, either lymphoid or epithelial. Although Faber et 25 years ago. Burrows7 in 1931, on the basis of observations on cases dying early in the course, went so far as to consider poliomyelitis a disease of the lymphatic system, which occasionally might involve the CNS. Landon and Smith' who reported 96 fatal cases in the 1931 New York City epidemic, probably the largest published series of complete human autopsies, noted that "the most exaggerated picture of the lymphatic structural involvement in poliomyelitis was that seen in the lymphoid tissues of the lower ileum and cecum." The changes included congested, hyperplastic follicles and Peyer's patches, and in some instances erosion and ulceration; all of these were much more striking in patients dying early in the course rather than later in convalescence. Similar alterations were found in the tonsils and spleen, but only minimal changes in the peripheral nodes. 30, Nove'mber, 1957 chimpanzees (in two or three days or even less) suggests that invasion of the blood stream occurs from sites of early multiplication either in the alimentary tract or other extraneural tissues. Sabine3 has pointed out that it is not likely to be the alimentary tract, since attenuated strains which multiply well in the gut fail to invade the blood in significant amounts. Wenner and Komitsukae1 demonstrated that high titers of virus can be found in the blood and in a variety of extraneural tissues (lymph nodes, GI tract, muscle) of cynomolgus monkeys inoculated intramuscularly with a Brunhilde strain of high paralytogenic capacity, and sacrificed early enough so that only trace amounts had appeared in the CNS. In orally infected chimpanzees sacrificed in the viremic period but before CNS invasion, Bodian8 found virus in considerable amounts in the alimentary tract, the regional and distal lymph nodes, and the brown fat. The evidence suggests that with virulent, paralytogenic strains, multiplication occurs extensively in various extraneural sites and this multiplication results in viremia. With attenuated strains, on the other hand, as Sabin has shown,' infection is more restricted, involving chiefly the alimentary tract and regional nodes, only minimal multiplication (if any at all) occurring more distally in the R.E. system, spleen, peripheral nodes, and perhaps other tissues; and under these circumstances virus fails to appear in the blood stream.
A close parallel to this course of events has been demonstrated by 0rskov and Jensen (quoted by Madsen') for an enteric infection of mice, induced by feeding Salmonella typhimurium. When fully virulent bacteria were fed, it was found that the organisms could be isolated first from the lymph follicles of the intestinal tract; this was followed rapidly by their appearance in regional lymph nodes, then in more distal parts of the R.E. system, the spleen, liver, and finally in the blood. In contrast, when mice were fed the same strain of bacteria which had been attenuated by serial passage at high temperatures, multiplication was demonstrated at considerable levels in intestinal lymph follicles, to a much lesser extent than with virulent strains in mesenteric nodes, spleen, and liver, and never was the organism cultured from the blood. Further decrease in virulence led to infections which involved only the intestinal lymph follicles.
A comparison of the findings on virus assay of chimpanzees infected with attenuated strains' and virulent strains8 suggests that in poliomyelitis, as with the enteric infection of mice studied by 0rskov and his colleagues,' both attenuated and virulent strains multiply in the same sites but to different extents and under different genetic controls. The loss of "invasiveness" or "virulence" characteristic of attenuated strains is associated with a reduced capacity to multiply in extraneural sites, which in turn is associated with absence of viremia.4
The significance of viremia in poliomyelitis is a part of the problem of how virus reaches the CNS. Does it invade directly from the blood? Or does it travel from the periphery via nervous pathways and is viremia merely an incidental occurrence? This also remains a controversial issue. Actually, there is a good deal to indicate that both mechanisms may play a role under certain circumstances. That poliovirus can travel and invade by way of nervous tissue once inside nerve cells is a well-established fact and has been thoroughly documented by many workers. But it does not follow that such is the required or even the usual course of events in the natural infection.
In summarizing the evidence favoring invasion from the blood, which seems to me the more likely explanation, the remarkably constant association of viremia and CNS invasiveness stands out strikingly. Although this association does not prove that CNS virus is blood-borne, it is difficult to relegate the correlation to a position of insignificance. Other findings which favor CNS invasion via the blood stream include: (i) the demonstration by German and Trask'7 of the regular occurrence of paralysis in monkeys inoculated cutaneously into a completely denervated limb; (ii) the experiments of Bodian2 in which large doses of a virulent strain of virus introduced intravascularly resulted in paralysis with a short incubation period comparable to that following intracerebral inoculation; (iii) the fact that low levels of serum antibody produced by vaccination'5 or injection of gamma globulin'9 protect against the paralytic disease, most probably by blocking the viremic phase of infection.
Sabin,3 who favors the view that invasion occurs by the neural route, believes that this blocking effect occurs not at the vascular level but at the cellular one, and that serum antibody prevents the progress of virus from extraneural sites of multiplication in the alimentary tract and elsewhere to peripheral nerve endings with which the cells are in close connection.
Faber,'0 whose view is that primary multiplication takes place in ganglia and CNS invasion occurs from peripheral neural connections, visualizes the antibody present in mucus in the oropharynx as blocking primary neural entry. In both Sabin's and Faber's interpretation, antibody is considered to act at the cellular level rather than at the vascular one. If this is the case, however, one would expect that alimentary tract infection as well as CNS invasion would be prevented by the presence of circulating antibody. Instead, alimentary infection has been shown to occur in the presence of even relatively high titers of serum antibody.7"
The evidence favoring neural invasion rests largely on the demonstration of lesions and virus in peripheral ganglia early in the course of infection induced by virus feeding. Faber et al. have shown this repeatedly in cynomolgus monkeys fed virulent strains of virus. That it is a somewhat irregular occurrence is suggested by the results of Faber and his coworkers" and by Bodian's findings that in only 2 of 8 chimpanzees fed virulent strains could trace amounts be detected in trigeminal and coeliac ganglia.' Sabin has recently reported that in a chimpanzee infected with an attenuated strain, small amounts of virus were isolated from superior cervical and thoracic spinal sympathetic ganglia. The interpretation of these observations as indicative that CNS invasion necessarily occurs via neural pathways is not convincing. Actually if, as the results indicate, both virulent and attenuated strains may rapidly infect ganglia, this would argue that such peripheral invasion occurs regularly but it is not an important aspect of virulence. Obviously the data are not extensive enough to permit a final definitive interpretation.
INFECTION IN THE PRESENCE OF ANTIBODY
Studies by Brown and his associates,' by Fox et al.,' Horstmann et al.," and othere "' have shown that persons who already have specific antibodies as a result of previous natural infection do not readily become infected when exposed to a case of poliomyelitis or poliomyelitic infection in the family. In contrast, more than 90 per cent of susceptible, antibody-negative individuals become infected under similar circumstances. Recent field investigations have been concerned with the question, is there a qualitative difference in the immunity resulting from natural infection as compared to that which follows vaccination with Salk vaccine or inoculation with gamma globulin? Brown et al.' showed that gamma-globulin-inoculated children, when exposed to a case of poliomyelitis in their families, became infected and excreted virus as readily as did susceptible children who had not received gamma globulin. Similarly, several field studies carried out since 1954"'"' indicate that vaccination with formalinized vaccine also fails to affect the incidence of alimentary infection among vaccinees on exposure to an infected person in the home.
This problem has also been investigated by observing the responses to ingestion of attenuated strains of poliovirus by individuals with naturally acquired and formalinized vaccine-induced antibodies. Koprowski et al. ' found that none of 3 individuals with antibodies to type II naturally acquired showed antibody rises, but 2 of them excreted virus on single occasions 5 and 23 days after ingestion of the TN type II strain. Sabin has compared the responses of 8 "naturally immune" and 8 "vaccine immune" persons following feeding of attenuated strains, and found that low levels of naturally acquired antibody protected against alimentary infection, whereas prefeeding vaccine-acquired antibody at levels up to 256 failed to inhibit multiplication in the alimentary tract in any of the volunteers tested.
We have been concerned with this problem, also, and have carried out two human trials with attenuated strains generously made available to us by Dr. Sabin. In the first one' a type III strain was fed to 5 individuals, 4 of whom became infected. The three whose prefeeding antibody was naturally acquired had brief periods of virus excretion in the feces 6 to 9 days, and acquired type I antibody at a level of 1: 64.* Following ingestion of a large dose of attenuated type I virus in capsule form, he became infected, as evidenced by a gradual rise in specific antibody from 64 to 1024 over a period of 56 days. Virus excretion, however, was minimal, positive stool specimens being obtained on the 1st and 6th days only, and the throat being consistently negative. There was no significant CF response. This re-infection, then, in a naturally immune individual resulted in barely detectable amounts of virus in the intestinal tract, yet gave a significant (8 fold 
Figure 3 is also concerned with a naturally immune person who was fed virus in liquid form. In spite of the large dose, his throat was apparently not infected, and virus excretion in the stools was small in amount and strikingly intermittent. His antibody rise was slow and not very high; there was no significant CF response. The pattern is similar to that in the previous individual who also had naturally acquired antibody, and to the one other naturally immune person who became infected: all of these had minimal and intermittent excretion of virus in the feces, but definite rises in neutralizing antibody.
Turning now to "vaccine-immune" persons who became infected: #503 * The antibody levels of all individuals reported in this study were determined by the colorimetric neutralization test.n ( Figure 4 ) with a prefeeding neutralizing antibody level of 64, was fed virus in liquid form. He excreted virus in the throat from the 1st through the 9th day, in the feces steadily through the 11th day, and intermittently thereafter through the 38th day. He had a sharp rise in both neutralizing and CF antibodies, beginning on the 10th day.
In contrast, with respect to virus in the throat, is #540 (Figure 5 mittently from the 3d through the 21st day, in titers, usually of 3.5 to 4.5 logs per gram. Sharp rises in neutralizing and CF antibodies began on days 7 and 10. Thus, although the throat was not infected, this individual excreted virus and developed antibodies as promptly as did those liquid-fed individuals with positive throat swabs. The patterns of response, then, of naturally immune and vaccinated persons with more or less comparable prefeeding antibody levels who became infected after ingestion of attenuated type I poliovirus, differed, as illustrated in the charts (Figs. 2-5) ; the 2 vaccinated individuals excreted relatively larger amounts of virus steadily during the first 2 weeks at least, and developed rises in both neutralizing and CF antibodies; the 2 naturally immune excreted little virus in the feces, excretion was intermittent, and while they developed neutralizing antibody rise, there was no significant CF rise.
Spread of infection to associates. The next problem considered was the ease-or difficulty-with which an attenuated strain of poliovirus might spread to close associates of infected individuals. The population under study consisted of 69 individuals, all living in the same cottage, but roughly divided into two groups, the older in the North Wing and the younger in the South Wing. Essentially the conditions of living were analogous to those S-503-VACCINE IMMUNE -LIQUID FED le TCDs ATTENUATED TYPE I POUOVIRUS. existing in family life, but the amount of fecal contamination of the environment was far greater because the subjects were low-grade mental defectives. In this situation, as reported above, 13 of 20 individuals fed virus became infected; and the degree of spread to the 49 associates was considerable ( 
DISCUSSION
The results of this trial confirm certain earlier observations and provide additional data on human responses to poliomyelitis virus infection, the relative nature of immunity, and the existence of qualitative differences between naturally acquired and vaccine-induced immunity.
As in previous similar studies a difference was observed in these two groups in that individuals with naturally acquired antibody were far more resistant to infection than were those with vaccine-acquired antibody of approximately the same level. This difference might be explained by assuming that the first line of defense is a tissue barrier ( ? local immunity) based on one or more previous experiences of the alimentary tract with living, multiplying virus. The second line of defense then becomes the presence of circulating antibody. Another possible explanation is that "tissue immunity" does not enter the picture, but there are qualitative differences in the antibody produced by the two different mechanisms, and higher levels of vaccine-induced than of natural antibody are required to prevent infection of the alimentary tract. There is some evidence that such qualitative differences do exist." Thus Sabin's so-called "low-avidity" neutralizing antibody follows vaccination, and appears also in the acute phase of poliomyelitic infection; in contrast is "high-avidity" antibody which is found in convalescence from natural infection or following infection with an attenuated strain.' As to whether very high levels, i.e. >1000, of vaccine-induced antibody will offer the same protection against intestinal infection afforded by lower levels of natural antibody, there is no direct evidence available. However, the experience of Sabine who found that three volunteers with prefeeding titers of 1: 256 were readily infected with an attenuated type I strain, indicates at least that moderately high levels of vaccine-induced antibody are not effective in this respect.
Of the many variables involved in determining responses on exposure to polioviruses, the immune barriers and the sites at which they operate are of primary importance in terms of immunization. The present state of knowledge does not allow more than general conclusions about this aspect. It is clear that circulating antibody and probably tissue barriers are involved in limiting the infectious process, in keeping it localized to the alimentary tract and regional lymphoid structures, in preventing spread to the CNS either from the blood stream, or along neural pathways. The effectiveness of the blocking mechanisms is governed to a considerable extent by the virulence of the infecting strain, and the dosage of virus or degree of exposure. That naturally acquired immunity is more "solid" than vaccine-acquired immunity seems likely, and the probability is great that it is also more durable. Nevertheless, by enhancing the potency of the formalinized vaccine, its effectiveness may, in the future, compare more favorably with that achieved by natural infection. In the meantime, however, there is still much to be learned about human responses to polioviruses. For this reason, we believe that the pursuit of problems of active immunization with attenuated viruses is an important area of investigation in terms of the pathogenesis of poliomyelitis and immunization against the infection as well as the disease.
